相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prevalence of Contraindications and Prescription of Pharmacologic Therapies for Gout
Robert T. Keenan et al.
AMERICAN JOURNAL OF MEDICINE (2011)
The appropriate use of non-steroidal anti-inflammatory drugs in rheumatic disease: opinions of a multidisciplinary European expert panel
Gerd Burmester et al.
ANNALS OF THE RHEUMATIC DISEASES (2011)
Using Allopurinol Above the Dose Based on Creatinine Clearance Is Effective and Safe in Patients With Chronic Gout, Including Those With Renal Impairment
Lisa K. Stamp et al.
ARTHRITIS AND RHEUMATISM (2011)
Gout therapeutics: new drugs for an old disease
Christopher M. Burns et al.
LANCET (2011)
NSAID Use Selectively Increases the Risk of Non-Fatal Myocardial Infarction: A Systematic Review of Randomised Trials and Observational Studies
Luis Alberto Garcia Rodriguez et al.
PLOS ONE (2011)
Existing and Emerging Therapies for Acute Gout and Long-Term Urate Lowering
Lisa K. Stamp et al.
CURRENT RHEUMATOLOGY REVIEWS (2011)
Association of Uric Acid With Change in Kidney Function in Healthy Normotensive Individuals
Gianni Bellomo et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2010)
Gout, Allopurinol Use, and Heart Failure Outcomes
George Thanassoulis et al.
ARCHIVES OF INTERNAL MEDICINE (2010)
High Versus Low Dosing of Oral Colchicine for Early Acute Gout Flare Twenty-Four-Hour Outcome of the First Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Comparison Colchicine Study
Robert A. Terkeltaub et al.
ARTHRITIS AND RHEUMATISM (2010)
Canakinumab for the Treatment of Acute Flares in Difficult-to-Treat Gouty Arthritis Results of a Multicenter, Phase II, Dose-Ranging Study
Alexander So et al.
ARTHRITIS AND RHEUMATISM (2010)
Effect of hydrochlorothiazide on the pharmacokinetics and pharmacodynamics of febuxostat, a non-purine selective inhibitor of xanthine oxidase
Brian Grabowski et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2010)
Effect of Allopurinol in Chronic Kidney Disease Progression and Cardiovascular Risk
Marian Goicoechea et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2010)
High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes Results of a 6-year follow-up
Linda H. Ficociello et al.
DIABETES CARE (2010)
Should Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) be Prescribed to the Older Adult?
Robert L. Barkin et al.
DRUGS & AGING (2010)
The prognostic impact of allopurinol in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention
E. Rentoukas et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2010)
Effect of high-dose allopurinol on exercise in patients with chronic stable angina: a randomised, placebo controlled crossover trial
Awsan Noman et al.
LANCET (2010)
The urate-lowering Efficacy and Safety of Febuxostat in the Treatment Hyperuricemia of Gout: The CONFIRMS trial
C. Dejaco et al.
JOURNAL FUR MINERALSTOFFWECHSEL (2010)
The urate-lowering efficacy and safety of febuxostat in the treatment of the hyperuricemia of gout: the CONFIRMS trial
Michael A. Becker et al.
ARTHRITIS RESEARCH & THERAPY (2010)
Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol
M. K. Reinders et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
The interleukin 1 inhibitor rilonacept in treatment of chronic gouty arthritis: results of a placebo-controlled, monosequence crossover, non-randomised, single-blind pilot study
R. Terkeltaub et al.
ANNALS OF THE RHEUMATIC DISEASES (2009)
Acid-related disorders in the elderly
Marilisa Franceschi et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2009)
The role of hyperuricemia in vascular disorders
N. Lawrence Edwards
CURRENT OPINION IN RHEUMATOLOGY (2009)
Gender-dependent impacts of body mass index and moderate alcohol consumption on serum uric acid-an index of oxidant stress status?
Paivikki I. Alatalo et al.
FREE RADICAL BIOLOGY AND MEDICINE (2009)
Clinical Efficacy and Safety of Successful Longterm Urate Lowering with Febuxostat or Allopurinol in Subjects with Gout
Michael A. Becker et al.
JOURNAL OF RHEUMATOLOGY (2009)
Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study
H. R. Schumacher et al.
RHEUMATOLOGY (2009)
Allopurinol and mortality in hyperuricaemic patients
Andrew J. Luk et al.
RHEUMATOLOGY (2009)
Colchicine Update: 2008
Robert A. Terkeltaub
SEMINARS IN ARTHRITIS AND RHEUMATISM (2009)
Effects of Febuxostat Versus Allopurinol and Placebo in Reducing Serum Urate in Subjects With Hyperuricemia and Gout: A 28-Week, Phase III, Randomized, Double-Blind, Parallel-Group Trial
H. Ralph Schumacher et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2008)
Effect of food or antacid on pharmacokinetics and pharmacodynamics of febuxostat in healthy subjects
Reza Khosravan et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2008)
A benefit-risk assessment of benzbromarone in the treatment of gout - Was its withdrawal from the market in the best interest of patients?
Ming-Han H. Lee et al.
DRUG SAFETY (2008)
The effect of age and gender on pharmacokinetics, pharmacodynamics, and safety of febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase
Reza Khosravan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2008)
Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial
Hein J. E. M. Janssens et al.
LANCET (2008)
In vitro drug-drug interaction studies with febuxostat, a novel non-purine selective inhibitor of xanthine oxidase: plasma protein binding, identification of metabolic enzymes and cytochrome P450 inhibition
M. Mukoyoshi et al.
XENOBIOTICA (2008)
Menopause, postmenopausal hormone use and serum uric acid levels in US women - The Third National Health and Nutrition Examination Survey
A. Elisabeth Hak et al.
ARTHRITIS RESEARCH & THERAPY (2008)
Effect of treatment of hyperuricemia with allopurinol on blood pressure, creatinine clearence, and proteinuria in patients with normal renal functions
Mehmet Kanbay et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2007)
Elderly-onset gout: a review
Francesco De Leonardis et al.
RHEUMATOLOGY INTERNATIONAL (2007)
Lowering serum uric acid levels:: What is the optimal target for improving clinical outcomes in gout?
Fernando Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
The role of interleukin-1 and the inflammasome in gout - Implications for therapy
Richard M. Pope et al.
ARTHRITIS AND RHEUMATISM (2007)
British Society for Rheumatology and British Health Professionals in rheumatology guideline for the management of gout
Kelsey M. Jordan et al.
RHEUMATOLOGY (2007)
Lumiracoxib 400 mg once daily is comparable to indomethacin 50 mg three times daily for the treatment of acute flares of gout
R. E. Willburger et al.
RHEUMATOLOGY (2007)
Comparison of oral prednisolone/paracetamol and oral indomethacin/paracetamol combination therapy in the treatment of acute goutlike arthritis: A double-blind, randomized, controlled trial
Chi Yin Man et al.
ANNALS OF EMERGENCY MEDICINE (2007)
Hyperuricaemia predicts poor outcome in patients with mild to moderate chronic heart failure
Ewa A. Jankowska et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2007)
The rate of NSAID-induced endoscopic ulcers increases linearly but not exponentially with age: a pooled analysis of 12 randomised trials
Maarten Boers et al.
ANNALS OF THE RHEUMATIC DISEASES (2007)
A pilot study of IL-1 inhibition by anakinra in acute gout
Alexander So et al.
ARTHRITIS RESEARCH & THERAPY (2007)
EULAR evidence based recommendations for gout.: Part II:: Management.: Report of a task force of the EULAR standing committee for international clinical studies including therapeutics (ESCISIT)
W. Zhang et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
Pharmacokinetic interactions of concomitant administration of febuxostat and NSAIDs
Reza Khosravan et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2006)
Therapy Insight: how changes in renal function with increasing age affect cardiovascular drug prescribing
CM Wyatt et al.
NATURE CLINICAL PRACTICE CARDIOVASCULAR MEDICINE (2006)
Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level
YP Siu et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2006)
Quality of care indicators for gout management
TR Mikuls et al.
ARTHRITIS AND RHEUMATISM (2004)
Efficacy and safety profile of treatment with etoricoxib 120 mg once daily compared with indomethacin 50 mg three times daily in acute gout -: A randomized controlled trial
BR Rubin et al.
ARTHRITIS AND RHEUMATISM (2004)
Significance of hyperuricemia as a risk factor for developing ESRD in a screened cohort
K Iseki et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Effects of statin treatment on uric acid homeostasis in patients with primary hyperlipidemia
HJ Milionis et al.
AMERICAN HEART JOURNAL (2004)
Amlodipine reduces cyclosporin-induced hyperuricaemia in hypertensive renal transplant recipients
J Chanard et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Effects of combination treatment using anti-hyperuricaemic agents with fenofibrate and/or losartan on uric acid metabolism
S Takahashi et al.
ANNALS OF THE RHEUMATIC DISEASES (2003)
Uric acid and survival in chronic heart failure - Validation and application in metabolic, functional, and Hemodynamic staging
SD Anker et al.
CIRCULATION (2003)
Long-term efficacy of hyperuricaemia treatment in renal transplant patients
F Perez-Ruiz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2003)
Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout
MD Feher et al.
RHEUMATOLOGY (2003)
Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey
J Coresh et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2003)
Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output
F Perez-Ruiz et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2002)
Randomised double blind trial of etoricoxib and indometacin in treatment of acute gouty arthritis
HR Schumacher et al.
BMJ-BRITISH MEDICAL JOURNAL (2002)
Fulminant hepatic failure associated with benzbromarone treatment: A case report
M Arai et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2002)
Serum uric acid and renal prognosis in patients with IgA nephropathy
I Ohno et al.
NEPHRON (2001)
Post-cardiac transplantation gout: Incidence of therapeutic complications
A Wluka et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2000)
Fatal fulminant hepatic failure associated with benzbromarone
H Wagayama et al.
JOURNAL OF HEPATOLOGY (2000)
分享论文
